Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effectiveness of intravenous ketamine in adults with treatment-resistant major depressive disorder and bipolar disorder presenting with prominent anxiety: Results from the Canadian Rapid Treatment Center of Excellence.
McIntyre RS, Rodrigues NB, Lipsitz O, Nasri F, Gill H, Lui LM, Subramaniapillai M, Kratiuk K, Teopiz K, Ho R, Lee Y, Mansur RB, Rosenblat JD. McIntyre RS, et al. Among authors: rodrigues nb. J Psychopharmacol. 2021 Feb;35(2):128-136. doi: 10.1177/0269881120954048. Epub 2020 Oct 11. J Psychopharmacol. 2021. PMID: 33040665
Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS, Carmona NE, Mansur RB, Lee Y, Park HJ, Rodrigues NB, Subramaniapillai M, Rosenblat JD, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Shekotikhina M, Zhou AJ, Rong C, Harrison J, McIntyre RS. Cha DS, et al. Among authors: rodrigues nb. Scand J Pain. 2017 Apr;15:62-67. doi: 10.1016/j.sjpain.2016.12.004. Epub 2017 Jan 10. Scand J Pain. 2017. PMID: 28850348 Free article.
Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder.
Cha DS, Carmona NE, Rodrigues NB, Mansur RB, Lee Y, Subramaniapillai M, Phan L, Cha RH, Pan Z, Lee JH, Lee J, Almatham F, Alageel A, Rosenblat JD, Shekotikhina M, Rong C, Harrison J, McIntyre RS. Cha DS, et al. Among authors: rodrigues nb. J Affect Disord. 2018 Oct 1;238:228-232. doi: 10.1016/j.jad.2018.05.006. Epub 2018 Jun 1. J Affect Disord. 2018. PMID: 29886204
Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder.
McIntyre RS, Lee Y, Carmona NE, Subramaniapillai M, Cha DS, Lee J, Lee JH, Alageel A, Rodrigues NB, Park C, Ragguett RM, Rosenblat JE, Almatham F, Pan Z, Rong C, Mansur RB. McIntyre RS, et al. Among authors: rodrigues nb. Harv Rev Psychiatry. 2018 Sep/Oct;26(5):241-249. doi: 10.1097/HRP.0000000000000171. Harv Rev Psychiatry. 2018. PMID: 30188336 Review.
Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression.
Mansur RB, Delgado-Peraza F, Subramaniapillai M, Lee Y, Iacobucci M, Rodrigues N, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, Raison CL, Chawla S, Nogueras-Ortiz C, McIntyre RS, Kapogiannis D. Mansur RB, et al. Cells. 2020 Apr 6;9(4):895. doi: 10.3390/cells9040895. Cells. 2020. PMID: 32268604 Free PMC article. Clinical Trial.
The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
McIntyre RS, Lipsitz O, Rodrigues NB, Lee Y, Cha DS, Vinberg M, Lin K, Malhi GS, Subramaniapillai M, Kratiuk K, Fagiolini A, Gill H, Nasri F, Mansur RB, Suppes T, Ho R, Rosenblat JD. McIntyre RS, et al. Among authors: rodrigues nb. Bipolar Disord. 2020 Dec;22(8):831-840. doi: 10.1111/bdi.12941. Epub 2020 Jul 8. Bipolar Disord. 2020. PMID: 32406161
Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence.
Rodrigues NB, McIntyre RS, Lipsitz O, Lee Y, Cha DS, Nasri F, Gill H, Lui LMW, Subramaniapillai M, Kratiuk K, Lin K, Ho R, Mansur RB, Rosenblat JD. Rodrigues NB, et al. Expert Opin Drug Saf. 2020 Aug;19(8):1031-1040. doi: 10.1080/14740338.2020.1776699. Epub 2020 Jun 15. Expert Opin Drug Saf. 2020. PMID: 32539491
Leptin mediates improvements in cognitive function following treatment with infliximab in adults with bipolar depression.
Mansur RB, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, Iacobucci M, Rodrigues N, Nasri F, Rashidian H, Rosenblat JD, Brietzke E, Cosgrove VE, Kramer NE, Suppes T, McIntyre RS. Mansur RB, et al. Psychoneuroendocrinology. 2020 Oct;120:104779. doi: 10.1016/j.psyneuen.2020.104779. Epub 2020 Jun 20. Psychoneuroendocrinology. 2020. PMID: 32603956
Novel therapeutic targets in mood disorders: Pentoxifylline (PTX) as a candidate treatment.
Siegel AN, Rodrigues N, Nasri F, Wilkialis L, Lipsitz O, Lee Y, Gill H, Subramaniapillai M, Phan L, Majeed A, Lui LMW, Rashidian H, Ho R, Toma S, Goldstein BI, Mansur RB, McIntyre RS, Rosenblat JD. Siegel AN, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110032. doi: 10.1016/j.pnpbp.2020.110032. Epub 2020 Jul 4. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32634540 Review.
96 results